Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Gynecol Endocrinol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    January 2017
  1. WILDEMEERSCH D, Goldstuck ND, Jackers G
    Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Gynecol Endocrinol. 2017 Jan 13:1-4. doi: 10.1080/09513590.2016.1276164.
    PubMed     Text format     Abstract available


    December 2016
  2. GUIDA M, Di Carlo C, Troisi J, Gallo A, et al
    The sexuological impact of hormonal contraceptives based on their route of administration.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  3. BASTIANELLI C, Farris M, Bruno Vecchio RC, Rosato E, et al
    An observational study of adherence to combined oral contraceptive regimens.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  4. REZK M, Sayyed T, Ellakwa H, Zahran A, et al
    Metabolic changes in overweight and obese women above 35 years using Ethinylestradiol/drosperinone combined contraceptive pills: a 3-year case-control study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  5. PLOUVIER P, Peigne M, Gronier H, Robin G, et al
    Is the suppressive effect of cyproterone acetate on serum anti-Mullerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  6. FENG W, Jia YY, Zhang DY, Shi HR, et al
    Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
    Gynecol Endocrinol. 2016;32:147-50.
    PubMed     Text format     Abstract available


  7. DAKHLY DM, Bayoumi YA, Gad Allah SH
    Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial.
    Gynecol Endocrinol. 2016;32:116-9.
    PubMed     Text format     Abstract available


  8. PAOLETTI AM, Lello S, Di Carlo C, Orru M, et al
    Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation.
    Gynecol Endocrinol. 2016;32:61-4.
    PubMed     Text format     Abstract available


  9. LAGANA AS, Giacobbe V, Triolo O, Granese R, et al
    Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
    Gynecol Endocrinol. 2016;32:408-11.
    PubMed     Text format     Abstract available


    December 2015
  10. SAITO F, Tashiro H, Yamaguchi M, Honda R, et al
    Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  11. KUCERA R, Ulcova-Gallova Z, Topolcan O
    Effect of long-term using of hormonal contraception on anti-Mullerian hormone secretion.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  12. NAMLI KALEM M, Hizli D, Kamalak Z, Kosus A, et al
    Effect of combined oral contraceptive use on serum 25-hydroxy vitamin D levels and ultrasound parameters in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  13. GRANDI G, Napolitano A, Xholli A, Tirelli A, et al
    Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  14. ESKI YUCEL O, Gungor I, Gul A, Turgut M, et al
    Papillophlebitis associated with the use of oral contraceptive: a case report.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  15. YANASE T, Ishida M, Nishijima S, Morikawa K, et al
    Outcomes of treatment with cyclic administration of dienogest after ovarian endometriotic cystectomy.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  16. ROUSKOVA D, Mittmann K, Schumacher U, Dietrich H, et al
    Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  17. GIRIBELA CR, Consolim-Colombo FM, Nisenbaum MG, Moraes TL, et al
    Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  18. POLYZOS NP, Corona R, Van De Vijver A, Blockeel C, et al
    Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  19. YIN Q, Fischer L, Noethling C, Schaefer WR, et al
    In vitro-assessment of putative antiprogestin activities of phytochemicals and synthetic UV absorbers in human endometrial Ishikawa cells.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  20. KAYA MG, Yildirim S, Calapkorur B, Akpek M, et al
    Metformin improves endothelial function and carotid intima media thickness in patients with PCOS.
    Gynecol Endocrinol. 2015;31:401-5.
    PubMed     Text format     Abstract available


  21. PAOLETTI AM, Cagnacci A, Di Carlo C, Orru MM, et al
    Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
    Gynecol Endocrinol. 2015;31:384-7.
    PubMed     Text format     Abstract available


    April 2015
  22. GUZEL E, Buchwalder L, Basar M, Kayisli U, et al
    Effects of tibolone and its metabolites on prolactin and insulin-like growth factor binding protein-1 expression in human endometrial stromal cells.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  23. ANGIONI S, Nappi L, Pontis A, Sedda F, et al
    Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  24. YILDIZHAN R, Gokce AI, Yildizhan B, Cim N, et al
    Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  25. PAN J, Liu Y, Ke Z, Zhou C, et al
    Successive and cyclic oral contraceptive pill pretreatment improves IVF/ICSI outcomes of PCOS patients and ameliorates hyperandrogenism and antral follicle excess.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


  26. TURRA J, Granzotto M, Gallea M, Faggian D, et al
    Sertoli-Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism.
    Gynecol Endocrinol. 2015;31:18-21.
    PubMed     Text format     Abstract available


    July 2014
  27. YANASE T, Tsuneki I, Tamura M, Kurabayashi T, et al
    Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Gynecol Endocrinol. 2014.
    PubMed     Text format     Abstract available


  28. XU HJ, Ji XW, Hong Y, Zhu QL, et al
    Mini-dose GnRH-a long versus short protocol in patients >/= 35 years old undergoing in vitro fertilization.
    Gynecol Endocrinol. 2014;30:498-501.
    PubMed     Text format     Abstract available


    June 2014
  29. DI CARLO C, Savoia F, Morra I, Ferrara C, et al
    Effects of a prolonged, 72 hours, interval between mifepristone and gemeprost in second trimester termination of pregnancy: a retrospective analysis.
    Gynecol Endocrinol. 2014.
    PubMed     Text format     Abstract available


  30. ROUSKOVA D, Mittmann K, Schumacher U, Dietrich H, et al
    Effectiveness, tolerability and acceptance of an oral estradiol/levonorgestrel formulation for the treatment of menopausal complaints: a non-interventional observational study over six cycles of 28 days.
    Gynecol Endocrinol. 2014.
    PubMed     Text format     Abstract available


    May 2014
  31. MATSUURA M, Tamate M, Tabuchi Y, Takada S, et al
    Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient.
    Gynecol Endocrinol. 2014.
    PubMed     Text format     Abstract available


  32. MIYASHITA M, Koga K, Takamura M, Izumi G, et al
    Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis.
    Gynecol Endocrinol. 2014.
    PubMed     Text format     Abstract available


    April 2014
  33. SEVEN A, Yuksel B, Kilic S, Esen H, et al
    Effect of injectable medroxyprogesterone acetate and etonogestrel implants on GABA-A and serotonin receptors in white and gray matter of the brain: experimental study in rats.
    Gynecol Endocrinol. 2014;30:320-4.
    PubMed     Text format     Abstract available


    December 2013
  34. TU J, Lin G, Lu C, Gong F, et al
    A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF/ICSI.
    Gynecol Endocrinol. 2013.
    PubMed     Text format     Abstract available


    November 2013
  35. SUN Y , Fang M, Davies H, Hu Z, et al
    Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.
    Gynecol Endocrinol. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: